Centro de Investigacion Biomedica en Red de Salud Mental-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

  2. New Origins of Yeast, Plant and Bacterial-Derived Extracellular Vesicles to Expand and Advance Compound Delivery

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  3. Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome

    Biomedicines, Vol. 12, Núm. 1

  4. Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 49, Núm. 1, pp. E35-E44

2022

  1. Late-life physical activity relates to brain tissue synaptic integrity markers in older adults

    Alzheimer's and Dementia, Vol. 18, Núm. 11, pp. 2023-2035

2021

  1. Effects of Gαi2 and Gαz protein knockdown on alpha2A-adrenergic and cannabinoid CB1 receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1122-1135

  2. Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample

    Acta Neuropathologica, Vol. 141, Núm. 5, pp. 755-770

2019

  1. Reduced SNAP25 Protein Fragmentation Contributes to SNARE Complex Dysregulation in Schizophrenia Postmortem Brain

    Neuroscience, Vol. 420, pp. 112-128

2010

  1. Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: Antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients

    European Neuropsychopharmacology, Vol. 20, Núm. 10, pp. 721-730